Cencora Elects Frank Clyburn to Its Board of Directors
Cencora, Inc. (COR)
Last cencora, inc. earnings: 4/30 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.coresite.com/investor-overview
Company Research
Source: Business Wire
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Frank Clyburn as a new independent director, effective October 1, 2024. With the election of Mr. Clyburn, the Board of Directors will increase to thirteen members.“Cencora’s Board of Directors is pleased to welcome Mr. Clyburn as a director. His many years of executive experience, including within the pharmaceutical industry, will be an asset to the company as we continue to focus on long-term, sustainable growth,” said Mark Durcan, Lead Independent Director.“Frank is a tenured executive leader who will bring valuable insights and perspectives to his role as a member of our Board,” said Steven H. Collis, Chairman, President & Chief Executive Officer. “We look forward to benefiting from his expertise and guidance as we continue to execute against our pharmaceutical-centric strategy.”Mr. Clyburn recently served as Chief Executive Officer and as a member of the board
Show less
Read more
Impact Snapshot
Event Time:
COR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COR alerts
High impacting Cencora, Inc. news events
Weekly update
A roundup of the hottest topics
COR
News
- Cencora, Inc. (NYSE: COR) had its "neutral" rating re-affirmed by analysts at Bank of America Co.. They now have a $245.00 price target on the stock, down previously from $275.00.MarketBeat
- Frazier Healthcare Partners Adds Highly Experienced Pharma Executive to Growth Buyout TeamBusiness Wire
- Cencora, Inc. (NYSE: COR) had its price target lowered by analysts at Robert W. Baird from $287.00 to $283.00. They now have an "outperform" rating on the stock.MarketBeat
- Cencora, Inc. (NYSE: COR) had its price target raised by analysts at JPMorgan Chase & Co. from $280.00 to $287.00. They now have an "overweight" rating on the stock.MarketBeat
- Cencora, Inc. (NYSE: COR) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
COR
Earnings
- 7/31/24 - Beat
COR
Sec Filings
- 9/18/24 - Form 4
- 9/17/24 - Form 144
- 9/17/24 - Form 144
- COR's page on the SEC website